Bank of Montreal’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3K Buy
+14,109
New +$20.5K ﹤0.01% 3599
2020
Q1
– Sell
-1,648
Closed -$7K – 4663
2019
Q4
$7K Buy
1,648
+499
+43% +$3.1K ﹤0.01% 4643
2019
Q3
$10K Buy
1,149
+46
+4% +$503 ﹤0.01% 4425
2019
Q2
$14K Buy
+1,103
New +$15.6K ﹤0.01% 4384
2019
Q1
– Sell
-93
Closed -$2K – 4719
2018
Q4
$2K Buy
93
+49
+111% +$1.07K ﹤0.01% 4422
2018
Q3
$1K Buy
+44
New +$1.34K ﹤0.01% 4599

Other funds holding STIM

Bank of Montreal's STIM Position: Q2 2026 in Review

Bank of Montreal opened a new position in Neuronetics (STIM) in Q2 2026: 14,109 shares worth $18.3K. The stake represents ﹤0.01% of the portfolio and ranks #3599 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in STIM as recently as Q4 2019.

Bank of Montreal first reported a position in STIM in Q3 2018 and has held it in 6 quarters since. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Bank of Montreal held 14,109 shares of Neuronetics worth $18.3K as of Q2 2026.
  • Neuronetics was a new Bank of Montreal position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3599 holding.
  • Bank of Montreal first reported a position in Neuronetics in Q3 2018 and has held it in 6 quarters since.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.